Skip to main content
Clinical Trials/NCT05399628
NCT05399628CompletedNot Applicable

LISA Catheter With Marked vs. Unmarked Tip in Extremely Low Birth Weight Infants With RDS: a Crossover Randomized Controlled Manikin Trial

University Hospital Padova1 site in 1 country50 target enrollmentStarted: June 6, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
50
Locations
1
Primary Endpoint
Number of participants who will achieve the positioning of the device at the correct depth in the trachea

Study Overview

Brief Summary

This is an unblinded, randomized, controlled, crossover (AB/BA) trial of surfactant treatment with LISA catheter with a marked tip vs. LISA catheter with an unmarked tip in a manikin simulating an extremely low birth weight infant. Participants will be level III NICU consultants and residents. Randomization will be performed using a computer-generated random assignment list. The primary outcome measure will be the positioning of the device at the correct depth in the trachea. The secondary outcome measures will be the time and number of attempts to achieve the correct depth and participant satisfaction.

Detailed Description

Although less invasive surfactant administration (LISA) offers some advantages in ventilation procedure and neonatal outcomes, achieving the correct depth in the trachea using a LISA catheter may be difficult. This may have some drawbacks such as impaired surfactant administration (reducing the efficacy of the procedure) or prolonged duration of the laryngoscopy (aggravating the invasiveness of the procedure).

The aims of the present study should be: i) positioning of the device at the correct depth in the trachea, ii) time and number of attempts to achieve the correct depth, iii) participant satisfaction.

This is an unblinded, randomized, controlled, crossover (AB/BA) trial of surfactant treatment with LISA catheter with a marked tip vs. LISA catheter with an unmarked tip in a manikin simulating an extremely low birth weight infant. Participants will be level III NICU consultants and residents. Randomization will be performed using a computer-generated random assignment list. The primary outcome measure will be the positioning of the device at the correct depth in the trachea. The secondary outcome measures will be the time and number of attempts to achieve the correct depth and participant satisfaction.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
None

Masking Description

Due to the characteristics of the intervention, both participants and outcome assessors cannot be masked. The statistician will be blind to the intervention arms.

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Level III NICU consultants and residents will be eligible to participate in the study

Exclusion Criteria

  • •Refusal to participate in the study.

Arms & Interventions

Surfactant administration with less invasive surfactant administration (LISA) marked tip catheter

Experimental

Participants will be assigned to perform the procedure with a LISA catheter with a marked tip

Intervention: Surfactant administration with less invasive surfactant administration (LISA) marked tip catheter (Device)

Surfactant administration with less invasive surfactant administration (LISA) unmarked tip catheter

Active Comparator

Participants will be assigned to perform the procedure with a LISA catheter with an unmarked tip

Intervention: Surfactant administration with less invasive surfactant administration (LISA) unmarked tip catheter (Device)

Outcomes

Primary Outcomes

Number of participants who will achieve the positioning of the device at the correct depth in the trachea

Time Frame: 5 minutes

Number of participants who will achieve the positioning of the device at the correct depth in the trachea (as assessed by the external observer using a laryngoscope).

Secondary Outcomes

  • Number of attempts for positioning the device in the trachea(5 minutes)
  • Participant opinion on using the device(10 minutes)
  • Time for positioning the device in the trachea(5 minutes)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Daniele Trevisanuto

Associate Professor

University Hospital Padova

Study Sites (1)

Loading locations...

Similar Trials